drugset / Trial / NCT02271997

Optimizing Iron Suppletion After Roux-en-Y Gastric Bypass

NCT02271997

Phase 4 Completed 120 enrolled Rijnstate Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

Multicentre randomized controlled trial to evaluate the optimal treatment for patients who developed an iron deficiency after Roux-en-Y Gastric bypass.

Timeline

Start
2014-12-04
Primary completion
2017-06-06
Completion
2017-06-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator FERROUS GLUCONATE ANHYDROUS Small molecule 695 mg Oral
Comparator Ferric carboxymaltose Other / unclassified 1000 mg Intravenous
Comparator Ferrous Sulfate Diagnostic / imaging agent 200 mg Oral